chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Had slight injection site soreness and slight fatigue the day of treatment. The following 12 to 24 hours I presented with sever fatigue and  severe body  and joint aches. I was negative for a fever the entire time.  24 to 36 hours after vaccination symptoms went away.
Information has been received from a health professional concerning a 20 year old female pt who was vaccinated with two doses of varicella vaccine. The reporter stated that "recent tests showed no seroconversion." Additional info has been requested.
Developed a DVT in left calf on 5/10/21.  Suffered a fractured metatarsal bone in left foot on 4/13/21 and a walking boot was prescribed.  Foot healed excellently but developed a DVT .
After the second vaccine on Feb 17, 2021, she was febrile for four days. However since then, she is experiencing headaches, nausea, and taste and smell disorders.  Have you seen other cases of this over three weeks post second vaccine?
We were out of stock on PEDIARIX. Hep B, Dtap, IPV had to be given separately. When drawing up vaccines instead of getting a Dtap I accidently picked up KINRIX (Dtap + IPV). A separate dose of IPV was also drawn up. Vaccines were verified by 2nd nurse. It was not until after they were given that I realized a KINRIX was given. Pt ended up receiving 2 doses of IPV. Provider notified CDC notified and state vaccine Rep notified. I was informed that pt may show signs of nausea/upset stomach but that coul dbe it. I was informed that the KINRIX and her 1st dose of Dtap could continue with schedule for 4 month vaccines. I called mother and explained what happened and she told me the Pt seemed to be ok but watching for adverse effect. I called back Pt had been vomiting and having pasty bowel movements. Pt was brought to the office to be treated. Pt mother reports spitting up after eating. Pt was given Ranitidine and U/S was ordered for Aug 14 to R/O pyloric stenosis.
Redness after first dose; Itching after dose; had been greater than 6 months since first dose; This case was reported by a pharmacist via call center representative and described the occurrence of erythema in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix and the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced erythema, pruritus and drug dose administration interval too long. On an unknown date, the outcome of the erythema, pruritus and drug dose administration interval too long were unknown.   It was unknown if the reporter considered the erythema and pruritus to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The pharmacist called to report that patient experienced redness and itching after first dose. Also that it had been greater than 6 months since first dose, which led to lengthening of the vaccination schedule. The reporter consented to follow up.  Caller did not have lot and expiration date of Shingrix at time of call.
Patient received booster shot of the Pfizer vaccine. She was not eligible as she was 15 years of age.
Case number PHEH2013US013759 is an initial spontaneous report received from a nurse on 25 un 2013. This case refers to a 17-year-old male patient. His medical history and concomitant medications were not reported. He was vaccinated only with MenCYW-135 component of MENVEO (batch number: A12025) intramuscularly on 24 Jun 2013. No adverse event was reported at the time of this report. No other information was available.
Doses administered to patients 18 hours after first vial puncture; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered to patients 18 hours after first vial puncture) in a 20-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 071F21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered to patients 18 hours after first vial puncture). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses administered to patients 18 hours after first vial puncture) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product use was provided by the reporter. No treatment medication was provided.  The vial was stored in the refrigerator after the first puncture.
Redness and swelling in left arm located between lower bicep/tricep through elbow. Patient presented to pharmacy around 11:00 am. Arm warm to touch; no rash. Advised to take ADVIL, BENADRYL at bedtime, ice and if worsened go to urgent care.
Headache  5 - 6 times per week. No headaches prior to vaccine.
Pt called to say whole arm and left side was in extreme pain to the point she "did not sleep a minute during the night." She was calling to see if she can take IBU.
Pt complained of severe decrease arm mobility. She went to see MD who gave Pt naproxen and stated vaccination given properly and had reaction to vaccine.
Vaccine was administered 11:45 on 12/19/00. At about 8 PM on 12/19/00 she had a slight numbness in her left hand. On 12/20/00, she experienced shoulder blade pain. The pain increased and varied in different parts on the left arm. She saw her primary MD on 01/02/01 or 01/03/01, because of pain and numbness in arm and fingers .The patient reported that she had "nerve damage all over her arm". Treatment continues with Vicodin, Tylenol, exercises, heating pad, follow up appointments.
VACCINE WAS GIVEN BEYOND USE DATE. VACCINE WAS RECEIVED IN REFRIGERATOR ON  03/07/2022 AND KEPT IN REFRIGERATOR IN APPROPRIATE TEMPERATURE (2-8 CELSIUS). VACCINE WAS GIVEN TO PATIENT 2 DAYS PAST THE 30 DAY TIME IN REFRIGERATOR
Nausea; Chills; Fever; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Mar2021 at 15:45 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Medical history included, asthma, hypertension and migraine. The patient had allergies to medications, food, or other products. The patient received unspecified medication within two weeks of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 08:30, the patient experienced nausea, chills, fever and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events nausea, chills, fever and fatigue was recovering.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Symptoms started to appear about half an hour to forty-five minutes after the vaccination:  1. The first set of symptoms were that I felt light-headed and I could feel that my neck muscles were a little bit tense when I moved my head to the sides. This first set of symptoms lasted about two to two-and-a-half hours before tapering off. 2. The second symptom which were chills started about three to three-and-a-half hours after vaccinations. The chills lasted about four hours before tapering off. 3. The last symptom was fever that started about nine to ten hours after the vaccination. The fever lasted for about twelve to fourteen hours  and tapered off the following morning.
I woke up in the middle of the night, shivering and shaking, unable to get warm. Was able to get back to sleep after putting on more clothing and wrapping up in a blanket. The next morning I woke up with flu-like symptoms: aching, weak, shaky, malaise. I rested and slept most of the day, and by next day started to feel better. As the day went on, I gradually felt better, and on the following day was feeling like myself again. No headaches, no fever. The symptoms came on suddenly, and improved gradually.
NO OUT BREAK OF FEVER BLISTER; This spontaneous report received from a patient concerned a 68 year old male of an unspecified race and ethnic origin. The patient's height and weight were not reported. The patient's concurrent conditions included: cold sores. The patient previously received covid-19 vaccine ad26. cov2.s (suspension for injection, route of administration, batch number were not reported, expiry: unknown) dose was not reported, (dose number in series was 1), 01 in total was administered on 31-MAR-2021 for prophylactic vaccination. On an unspecified date, following vaccination with covid-19 vaccine ad26.cov2.s, the patient did not have a fever blister (unexpected therapeutic benefit) (dose number in series was 1). The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration, batch number were not reported, expiry: unknown) dose was not reported, (dose number in series was 2), 01 in total was administered on 03-NOV-2021 for prophylactic vaccination. The batch number was not reported and has been requested. The patient's concomitant medications included lysine as product use for an unknown indication. On an unspecified date, following vaccination with covid-19 vaccine ad26.cov2.s, the patient did not have out break of fever blister. He had cold sores for about 45 years. The only thing that helped was L-Lysine (lysine), diet and avoiding L-Arginine. This was the longest he had gone without an episode (unexpected therapeutic benefit) (dose number in series was 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of no out break of fever blister was not reported (dose number in series was 2). This report was non-serious. This case, involving the same patient is linked to 20220104581.; Sender's Comments: V0- Medical assessment comment is not required as per standard procedure as case was assessed as non-serious.
pt recv vax APR96 & approx 72 hr later pt exp a pruritic rash on arm, trunk, & face;
This spontaneous report as received from a registered pharmacist refers to a female patient of unknown age. On an unspecified date, the patient was vaccinated with a dose of PNEUMOVAX23 (lot # dose and site of administration were not provided). No other co-suspects were reported. No concomitant medications were reported. On an unknown date, the patient had an unspecified reaction to PNEUMOVAX23 and went to ER at an unspecified hospital but was not admitted. At the time of the report, the patient's outcome was not provided. Additional information has been requested.
Varicella Lesions on torso (had received Varivax from previous MD)
The rash was approximately 3 inches by 3 inches/The patient mentions it itches more than anything ever in her life; It was really really bothersome, miserable, and It looked like a burn; Rash in right arm after taking the second dose; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (The rash was approximately 3 inches by 3 inches/The patient mentions it itches more than anything ever in her life), THERMAL BURN (It was really really bothersome, miserable, and It looked like a burn) and RASH (Rash in right arm after taking the second dose) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH PRURITIC (The rash was approximately 3 inches by 3 inches/The patient mentions it itches more than anything ever in her life), THERMAL BURN (It was really really bothersome, miserable, and It looked like a burn) and RASH (Rash in right arm after taking the second dose). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, RASH PRURITIC (The rash was approximately 3 inches by 3 inches/The patient mentions it itches more than anything ever in her life), THERMAL BURN (It was really really bothersome, miserable, and It looked like a burn) and RASH (Rash in right arm after taking the second dose) outcome was unknown.            Treatment included Neosporin Cream and Benadryl  Action taken with mRNA-1273 in response to the event was Not Applicable
On 8/21/21 at approximately 810am the patient was exiting the bathroom with a staff member and reported that she was not feeling well.  Patient was observed with shortness of breath.  T 97.2 P 105 R 22-26 BP 124/67.  O2 Sat 78-83% on Room air.  Resident mental status fluctuating with periods of lethargy but arousable.  EMS Activated.  Supplemental O2 applied via Nasal Cannula without improvement.  O2 Sat remained in the 80s.  O2 delivery changed to Non Rebreather mask at 15 l/m with O2 sat improving to 98%.  Respiratory rate without improvement.  Lung sounds diminished at R side.  Resident transferred to Hospital for evaluation.  The patient is currently diagnosed with diagnosis of bilateral pulmonary emboli.  No previous history.
Chest pain and heaviness  Hospitalized  Treated with NSAIDS, colchichine and IVIG
Patient reported sore arm shortly after vaccination.  Later in the evening a feeling of disorientation and dizziness.  Overnight experienced extreme nausea, headache, fever, chills, body aches, severe weakness and mental disorientation.  On the next day, patient was still unable to eat and was extremely weak with continued nausea and severe headache which was aided by Tylenol.  2/11 patient is still very weak and no appetite and a general feeling of malaise.
Fever to 102 x 3d starting 24DEC rash x 1d - mac/pap, on chest & face. No conjunctivitis, no cough, no koplik's; minimal coryza lt otitis rx Amox
Patient fainted three minutes after receiving the Moderna vaccine. Patient's mom was at clinic with her and reported  after the patient had fainted that the patient had played an outdoor La Crosse game in the heat & humidity the evening before receiving the MODERNA vaccine & had not eaten breakfast or had much to drink the day of the MODERNA vaccine. Provider who responded to take care of the patient indicated the patient was most likely dehydrated & needed IV fluids. Blood pressure was 97/58; pulse 64; Oxygen saturation 96%. Patient became responsive within 30-45 seconds from fainting but then fainted a second time when being transferred from a wheelchair to an exam room table. Patient was very tired and would be awakened & responsive when  patient mom speaking to her, but faded in & out. 911 called & patient transported to hospital for hydration with IV fluids.
Patient received Janssen Covid-19 vaccine 03/15/21. After discussion with PCP he decided to obtain the Pfizer Covid-19 7/24/21. He stated that he is worried about the Delta varient.
Twitching muscle spasms all over the body randomly every few minutes when trying to fall asleep and during sleep. (Not hypnic jerk)
sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 13-Feb-2021, PAIN IN EXTREMITY (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The treatment medications reported to be taken by the patient were not provided.
side effects; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (side effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On an unknown date, the patient experienced ADVERSE EVENT (side effects). At the time of the report, ADVERSE EVENT (side effects) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Soreness at base of neck (swollen and tender) aching in elbows, knee, hip and back. 30min after receiving injection became nauseated but no vomiting. Soreness began next  morning in neck and joints. States no tenderness or pain 11/06/2009.
Patient reported shoulder injury from vaccine. Stated the arm hurt since the vaccine and has not gone away. Describes loss in range of motion and loss of strength.
Case number PHEH2014US015504 is an initial spontaneous report received from a health care professional on 31 Jul 2014. This report refers to an adolescent patient whose age and gender was not reported. The patient's medical history and concomitant medications were not reported. The patient was vaccinated with a booster dose of MENVEO (batch number: not reported) on an unspecified date. It was reported that 2 weeks after vaccination, the patient was presented with autoimmune symptoms (not further specified). The event outcome, seriousness and causality were not reported.
The report was first received from a practice manager on 07-SEP-2018, and it was recognized as non-valid because report did not obtain any patient identify. Follow-up information has been received from a practice manager on 18-SEP-2018. This spontaneous report refers to a patient of unknown age and gender. Information of concurrent condition, medical history and concomitant therapy was not provided. On 18-JAN-2018 and 26-JUL-2018, the patient was vaccinated with an improperly stored dose of GARDASIL 9 (strength and route were unknown) (lot# N021475 and expiration date 03-JAN-2020; lot# N022728 and expiration date 31-MAY-2020) for prophylaxis. No adverse event was reported. The excursion temperature on 08-NOV-2017, 16-NOV-2017, 23-JAN-2018, 06-JUN-2018, 03-JUL-2018 and 14-AUG-2018   was 47 degree Celsius for maximize 15 hours. The excursion temperature on 07-DEC-2017 was 50 degree Celsius for maximize 8.75 hours. The call was not because of data logger. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1810USA001951: US-009507513-1810USA001952: US-009507513-1810USA001953: US-009507513-1810USA001954: US-009507513-1810USA001955: US-009507513-1810USA001957: US-009507513-1810USA001958: US-009507513-1810USA001959: US-009507513-1809USA003709.
Event occurred after 2nd vaccine.  Presented to ED with shortness of breath.  O2 sat on room air at 80%. Pt states that he was COVID positive 2 weeks ago. Pt tested externally, outside medical facility
upper left thigh muscle ache; This is a spontaneous report from a contactable consumer, the patient. A 75-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot/batch no: unknown) as a first dose in the left arm on 12Feb2021 and (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot/batch no: EL3302) as a second dose on 07Mar2021 via an unspecified route of administration for COVID-19 vaccination (Age at vaccination: 75 years). Medical history included HBP (High Blood Pressure) and cholesterol. Concomitant medications included blood pressure (unspecified) and cholesterol medication(unspecified) from unknown dates to unknown dates for High blood pressure and Cholesterol. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The facility where the most recent COVID-19 vaccine was administered was at a pharmacy. On an unknown date, the patient experienced upper left thigh muscle ache (back of thigh) badly for a couple of weeks. (No accidents, falls, etc. that might have caused this). The patient did not receive treatment for the event of upper left thigh muscle ache. The outcome of the event of upper left thigh muscle ache was unknown. Information about lot/batch number cannot be obtained. No further information is expected.
during our covid vaccine clinic, we ended up giving 62 doses out of 60 vials. this was not realized until the end of the day when we had 2 doses left after we filled the 60 patient slots. there is apparently a small amount of overfill in the vials where 2 extra dose were able to be retrieved out of the 6 vials used. the patients did not receive a 'short dose' they received the full 0.5ml.  our state told us to report the overfill via VAERS. i will inform the nurses to only draw up 10 doses per vial at our next vaccine clinic.
Five days following second dose of COVID-19 vaccination my son began having a recurring rash.  He has no chronic medical conditions and has not been diagnosed with COVID-19 in the past.  His vaccination history is up-to-date with no prior allergic reaction to vaccines.  He does have a severe allergy to peanuts and treenuts.  He has developed a global widespread uticaria formation of a daily rash with maculopapular wheels.  The rash resolves within 15-30 minutes of Zyrtec administration but appears again globally throughout the body within 24 hours of taking Zyrtec.  He has tried taking Zyrtec consistently for various prolonged periods of time, but uticaria would resume after 24 hours of ceasing daily dosage.
After receiving my first dose, my arm was sore. On 08/11/2021, I woke up with hives all over my arm. My arm was hot, burning, and itchy. This continued for a few days. I put Benadryl gel on it. I went to the doctor and she gave me Ibuprofen to bring down the inflammation. It went away after awhile but it was still itchy. But on 08/24/2021, hives broke out all over my face and body again.  On 09/04/2021, my face was swollen as well as my lips and tongue. I went to Urgent Care. They gave me a steroid shot. I was also given an EpiPen and Prednisone. I am still dealing with hives all over my arms and body, which are red and itchy.
lt arm +induration 3-4inch;+erythema;no abscess formation;allerg rxn to DTAP in lt arm;cellulitis in lt arm;ice & dph & duricef;
Malaise lasting over 6 days, decreased appetite, arm pain, body aches, abdominal pain, diarrhea, blurred vision, ringing in the ear, difficulty concentrating
No adverse effects reported; a 19 month old male child received both PROQUAD and VARIVAX; This spontaneous report was received from a registered nurse referring to a 19 month old male patient. The patient's pertinent medical history, concurrent conditions and drug reactions/allergies were not provided.   On 30-APR-2019, the patient was vaccinated with both measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot # R020675, expiry date on 15-JAN-2020, for prophylaxis and varicella virus vaccine live (oka/merck) (VARIVAX) lot #R026547, expiri date on 17-SEP-2020. Both vaccines were properly stored without any prior temperature excursion and were reconstituted with properly stored sterile diluent. No adverse effects were reported.